Pfizer and BioNTech have announced that their vaccine candidate against COVID-19 achieved success in the first interim analysis from the phase 3 COVID-19 vaccine trial.
10th November 2020 •
comment
9th November 2020 •
comment
CONSIDERATIONS FOR EVALUATION OF COVID19 VACCINES
by World Health Organization
30th September 2020 •
comment
Submit an article
We welcome contributions from members. Please submit an article for review by our editorial team.
Upload nowCategories
- Clinical trials (8)
- Coronavirus (4)
- COVID-19 (WEPHREN Resources) (17)
- Infectious diseases (2)
- Lassa Fever (2)
- Maternal Health (1)
- Participatory Epidemiology (1)
- Vacancy (1)
- Vacccine Production (3)
- Vaccine Efficacy (6)
- Vaccine safety (9)
- West Africa (1)
- Workshop Reports (4)